Welcome to Medications.com
CollaGenex announces results of dose comparison study of rosacea - Pharmaceutical Business Review
Both treatments were administered as an adjunct to topical MetroGel 1%. The treatment duration was 16 weeks, and patients were evaluated for efficacy and ...
http://www.pharmaceutical-busines... |
Posted: Fri Jan 18 22:46:24 -0500 2008
MetroGel RSS Feed
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com |
Sleep Apnea
